Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）
Clinical trial NCT06107673 · RECRUITING
Trial details
- NCT number
- NCT06107673
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-30
- Primary completion
- 2026-12-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.